ALPS Advisors’s Tyra Biosciences TYRA Stock Holding History

ALPS Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.73M	Buy	79,051 +18,892	+31%	+$519K	0.01%	554
2026 Q2	$1.92M	Buy	60,159 +16,303	+37%	+$539K	0.01%	536
2026 Q1	$1.68M	Buy	43,856 +29	+0.1%	+$939	0.01%	439
2025 Q4	$1.15M	Buy	43,827 +19,127	+77%	+$351K	0.01%	520
2025 Q3	$346K	Sell	24,700 -4,029	-14%	-$45.9K	﹤0.01%	937
2025 Q2	$275K	Buy	+28,729	New	+$273K	﹤0.01%	954

Other funds holding TYRA

Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Auour Investments Woburn, Massachusetts $353M AUM 8.66% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

ALPS Advisors's TYRA Position: Q3 2026 in Review

ALPS Advisors increased its Tyra Biosciences (TYRA) stake by 31% in Q3 2026, buying an estimated $519K and bringing the position to 79,051 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #554.

ALPS Advisors first reported a position in TYRA in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.92M in Q2 2026. 32 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

ALPS Advisors held 79,051 shares of Tyra Biosciences worth $1.73M as of Q3 2026.
ALPS Advisors bought 18,892 Tyra Biosciences shares in Q3 2026, an estimated $519K.
Tyra Biosciences made up 0.01% of ALPS Advisors's portfolio in Q3 2026, its #554 holding.
ALPS Advisors first reported a position in Tyra Biosciences in Q2 2025 and has held it in 6 quarters since.
ALPS Advisors's Tyra Biosciences position peaked at $1.92M in Q2 2026.
32 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on ALPS Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.